Cite
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
MLA
Nayak, Lakshmi, et al. “Multicenter Phase 2 Study of Patupilone for Recurrent or Progressive Brain Metastases from Non-Small Cell Lung Cancer.” Cancer (0008543X), vol. 121, no. 23, Dec. 2015, pp. 4165–72. EBSCOhost, https://doi.org/10.1002/cncr.29636.
APA
Nayak, L., DeAngelis, L. M., Robins, H. I., Govindan, R., Gadgeel, S., Kelly, K., Rigas, J. R., Peereboom, D. M., Rosenfeld, S. S., Muzikansky, A., Zheng, M., Urban, P., Abrey, L. E., Omuro, A., & Wen, P. Y. (2015). Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer. Cancer (0008543X), 121(23), 4165–4172. https://doi.org/10.1002/cncr.29636
Chicago
Nayak, Lakshmi, Lisa M. DeAngelis, H. Ian Robins, Ramaswamy Govindan, Shirish Gadgeel, Karen Kelly, James R. Rigas, et al. 2015. “Multicenter Phase 2 Study of Patupilone for Recurrent or Progressive Brain Metastases from Non-Small Cell Lung Cancer.” Cancer (0008543X) 121 (23): 4165–72. doi:10.1002/cncr.29636.